Source link : https://www.newshealth.biz/health-news/wegovy-cut-albuminuria-by-half-in-non-diabetic-ckd/
SAN DIEGO — Semaglutide (Wegovy) reduced albuminuria in patients with overweight or obesity and chronic kidney disease (CKD) but without type 2 diabetes, a randomized trial showed. Among 101 patients, those who received 2.4-mg semaglutide for 24 weeks had a 52.1% (95% CI -65.5 to -33.4, PAmerican Society of Nephrology Kidney Week meeting. “The albuminuria […]
Author : News Health
Publish date : 2024-10-29 20:22:40
Copyright for syndicated content belongs to the linked Source.